Hospital
Ahmc Monterey Park Hospital LP
Ahmc Monterey Park Hospital LP was paid $10.85M by Medicaid between Jan 2018 and Dec 2024, across 151 billing codes. Its largest line is 0450, Emergency room services — 21% of everything it billed.
33Billing provider infoAHMC MONTEREY PARK HOSPITAL LP
MONTEREY PARK, CA 91754
MONTEREY PARK, CA 91754
33aNPI1780676221assigned 08/19/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.85M
24GClaims421,748
24DCodes billed151
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#173 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MARSH, LINDA controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 86,641 | $2.22M | |
| 2019 | 71,583 | $2.56M | |
| 2020 | 43,536 | $1.05M | |
| 2021 | 39,231 | $953K | |
| 2022 | 56,771 | $1.44M | |
| 2023 | 63,267 | $1.45M | |
| 2024incomplete | 60,719 | $1.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 21% | 54,870 | 50,757 | $2.28M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7.4% | 6,490 | 6,325 | $808K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 5,148 | 4,984 | $525K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.9% | 7,809 | 7,020 | $427K |
| 99199 | Unlisted special service, procedure or report | 3.3% | 6,364 | 5,731 | $359K |
| 80053 | Comprehensive metabolic panel | 3.2% | 15,036 | 14,213 | $349K |
| Z7502 | 3.0% | 8,935 | 8,833 | $320K | |
| J3490 | Unclassified drugs | 2.9% | 22,652 | 12,616 | $319K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 7,485 | 7,175 | $308K |
| 0360 | 2.4% | 2,784 | 2,172 | $263K | |
| 0750 | 2.3% | 1,786 | 1,616 | $248K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 13,132 | 12,604 | $237K |
139 more codes
| 99284 | Emergency room visit (serious) | 2.1% | 1,955 | $229K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 8,953 | $210K |
| 0710 | 1.8% | 5,132 | $199K | |
| 0270 | 1.8% | 15,186 | $193K | |
| 0250 | 1.7% | 15,029 | $189K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 5,216 | $166K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.4% | 2,060 | $150K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 10,377 | $149K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 18,635 | $143K |
| 99283 | Emergency room visit (moderate) | 1.2% | 1,789 | $128K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 6,176 | $122K |
| 81025 | 1.1% | 15,461 | $121K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.1% | 3,839 | $120K |
| A4217 | Sterile water/saline, 500 ml | 1.1% | 9,274 | $120K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.1% | 1,593 | $116K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.0% | 11,921 | $112K |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 1.0% | 784 | $110K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,298 | $81K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,014 | $81K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,475 | $64K |
| Z9725 | <1% | 1,467 | $63K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 983 | $58K |
| 81001 | <1% | 13,013 | $58K | |
| 84484 | <1% | 6,277 | $56K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,554 | $54K |
| 88313 | <1% | 1,595 | $54K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,210 | $54K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 304 | $52K |
| 83690 | <1% | 7,818 | $51K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 943 | $50K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,768 | $44K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,945 | $43K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 827 | $41K |
| 80306 | <1% | 2,150 | $37K | |
| 0272 | <1% | 2,472 | $36K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,287 | $34K |
| 83880 | <1% | 1,902 | $33K | |
| 85730 | <1% | 5,102 | $33K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,926 | $32K |
| Z7610 | <1% | 2,367 | $29K | |
| 88312 | <1% | 1,564 | $28K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,880 | $27K |
| 87040 | <1% | 1,503 | $27K | |
| 85610 | <1% | 5,148 | $26K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,058 | $25K |
| 94664 | <1% | 1,838 | $25K | |
| 73562 | <1% | 1,142 | $25K | |
| 73610 | <1% | 1,029 | $23K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 256 | $23K |
| 73630 | <1% | 1,036 | $22K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,099 | $20K |
| 0258 | <1% | 840 | $20K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 279 | $19K |
| 59025 | Fetal non-stress test | <1% | 225 | $19K |
| 76830 | Ultrasound, transvaginal | <1% | 324 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,507 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 324 | $16K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,101 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 566 | $14K |
| 87186 | <1% | 1,641 | $14K | |
| 82948 | <1% | 2,287 | $14K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,789 | $14K |
| 93971 | <1% | 172 | $13K | |
| 83605 | <1% | 1,276 | $12K | |
| 84702 | <1% | 853 | $11K | |
| 83735 | <1% | 2,148 | $11K | |
| 73030 | <1% | 554 | $11K | |
| 0762 | <1% | 37 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 717 | $10K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 252 | $8K |
| 27502 | <1% | 16 | $7K | |
| 82150 | <1% | 867 | $7K | |
| 73130 | <1% | 365 | $7K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 141 | $6K |
| 85379 | <1% | 693 | $6K | |
| 85027 | <1% | 1,033 | $6K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 578 | $6K |
| 94760 | <1% | 633 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 410 | $5K |
| 81002 | <1% | 1,518 | $5K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 454 | $5K |
| 72131 | <1% | 55 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,120 | $5K |
| 86900 | <1% | 649 | $5K | |
| 71250 | <1% | 41 | $4K | |
| 86901 | <1% | 884 | $4K | |
| 85007 | <1% | 971 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 702 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 663 | $3K |
| 0459 | <1% | 82 | $3K | |
| 82248 | <1% | 771 | $3K | |
| 99000 | <1% | 694 | $3K | |
| 0300 | <1% | 146 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 34 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 26 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 70 | $2K |
| A4649 | Surgical supply; miscellaneous | <1% | 1,371 | $2K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 410 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 49 | $2K |
| 90714 | <1% | 77 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 38 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 28 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 452 | $2K |
| 72110 | <1% | 52 | $1K | |
| 84703 | <1% | 258 | $1K | |
| 43264 | <1% | 12 | $1K | |
| 71010 | <1% | 84 | $1K | |
| 72100 | <1% | 55 | $1K | |
| 83520 | <1% | 97 | $990.34 | |
| 87420 | <1% | 40 | $685.79 | |
| 99152 | <1% | 14 | $653.10 | |
| 86850 | <1% | 132 | $564.61 | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 16 | $534.65 |
| 73080 | <1% | 38 | $492.56 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 95 | $476.71 |
| 73110 | <1% | 25 | $466.24 | |
| 29799 | <1% | 12 | $437.28 | |
| 74018 | <1% | 36 | $419.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 42 | $417.14 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 80 | $393.57 |
| 88304 | <1% | 48 | $383.09 | |
| 82805 | <1% | 12 | $336.95 | |
| 90715 | <1% | 12 | $324.55 | |
| 0320 | <1% | 68 | $320.17 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 22 | $313.96 |
| 73140 | <1% | 26 | $266.60 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 55 | $193.48 |
| 99070 | <1% | 127 | $159.90 | |
| 73100 | <1% | 13 | $147.94 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 43 | $130.36 |
| 0279 | <1% | 14 | $115.69 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 13 | $85.25 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 14 | $82.35 |
| 82550 | <1% | 13 | $63.32 | |
| 80076 | <1% | 15 | $56.07 | |
| 76818 | 0% | 56 | $0.00 | |
| 0760 | 0% | 12 | $0.00 | |
| 0636 | 0% | 30 | $0.00 | |
| 96376 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARSH, LINDA (SENIOR VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ahmc Garfield Medical Center LP | Monterey Park, CA | $17.83M |
| Ahmc Whittier Hospital Medical | Whittier, CA | $15.12M |
| Ahmc Anaheim Regional Medical | Anaheim, CA | $14.21M |
| Ahmc Greater El Monte Community | South El Monte, CA | $9.17M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $6.96M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $6.90M |
| Ahmc Seton Medical Center LLC | Daly City, CA | $5.21M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $1.57M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $249K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $176K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.